Author

James McAuliffe

University of OxfordORCID 0000-0002-4858-3191Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Benoı̂t J. Van den EyndeiD· 3 shared Carol Sze Ki LeungiD· 3 shared Emily E SteffkeiD· 3 shared Sara Abdel MalakiD· 3 shared Vinnycius Pereira AlmeidaiD· 3 shared Amanda WickiiD· 2 shared Hideho OkadaiD· 2 shared Hua SongiD· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Benoı̂t J. Van den EyndeORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Vaccination targeting the novel endogenous tumor-associated antigen Gpr149 induces protective immunity against checkpoint inhibitor-refractory SB28 glioblastoma

Emily E Steffke, Taijun Hana, Laila Latifi, Sara Abdel Malak, James McAuliffe, Vinnycius Pereira Almeida, Nicole Briceno, Meili Zhang, Dionne L. Davis, Wei Zhang, Hua Song, Michael E. Bryan, Hye Kim, Mark R. Gilbert, Hideho Okada, , Masaki Terabe

This study identifies Gpr149 as an endogenous antigen in SB28 glioblastoma that can be targeted by vaccination to induce protective immunity against checkpoint inhibitor-refractory tumors.

bioRxiv · Oct 30, 2026 · PreprintImmunology

CXCR3 on transferred T cells enables vaccine-boosted adoptive T-cell therapy in solid tumors

Vinnycius Pereira Almeida, Lucy C. Garner, Sara Abdel Malak, Amanda Wicki, James McAuliffe, Laurine Noblecourt, Silvia Panetti, Emily E Steffke, Aneesha Bhandari, Lyn Yong, Ali Amini, Claire L. Hutchings, Francesco Andreata, Yuanqin Yang, Audrey Gérard, , Carol Sze Ki Leung

This study shows that CXCR3 on transferred T cells enhances the effectiveness of combining adoptive T-cell therapy with viral-vector vaccines in solid tumors.

bioRxiv · Oct 11, 2026 · PreprintImmunology

Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity

Emily E Steffke, Laila Latifi, Taijun Hana, Ayaka Hara, Morgan Coombs, Jo Spurgeon, James McAuliffe, Vinnycius Pereira Almeida, Amanda Wicki, Sara Abdel Malak, Laurine Noblecourt, Caitlin J. Huguely, John C. Hancock, Silvia Panetti, Hye Kim, , Masaki Terabe

This study shows that viral vector vaccination induces brain-resident memory T cells that effectively combat glioblastoma, offering a potential therapeutic strategy.

bioRxiv · Jun 20, 2026 · PreprintImmunology